Entera Bio Presents Positive New Clinical Data from EB613 Phase 2 Trial Demonstrating Significant Bone Density Improvements in Early Postmenopausal Wo…

Consistency of BMD gains presented at NAMS 2025 demonstrate EB613’s efficacy in both young postmenopausal women and in women ...
Morningstar

BREAKING: Jewish National Fund-USA Fire Equipment Deployed to Raging Fires Throughout Israel

JERUSALEM, May 1, 2025 /PRNewswire/ -- As fast-moving wildfires sweep across the outskirts of Jerusalem and beyond, Jewish National Fund-USA—the official U.S. fundraising arm of Israel's Fire & Rescue ...

Alpha Tau Announces Receipt of Radioactive Material License for its New Hampshire Manufacturing Facility, Advancing Towards Commercial Readiness

Receipt of critical license marks significant milestone for first commercial-scale manufacturing facility for Alpha DaRT®, ...
WGNO

Alpha Tau Announces Grant of Expanded Radioactive License and Final Pre-Clinical Laboratory Regulatory Approval at its Jerusalem Headquarters

JERUSALEM, March 03, 2023 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. ("Alpha Tau", or the “Company”) (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT™, ...
WDAF-TV

Heal.Earth Launches "Heal Israel" Initiative in Partnership with Indigenous Embassy of Jerusalem and Ministry of Health

JERUSALEM, ISRAEL, Aug. 12, 2024 (GLOBE NEWSWIRE) -- Heal Earth, a global leader in spiritual renewal and humanitarian efforts, is thrilled to announce the launch of the "Heal Israel" initiative in ...
Morningstar

Dr. Mike Evans Announces the Establishment of the Annual Charlie Kirk Award

U.S. Ambassador to Israel Mike Huckabee praised the initiative, calling it a "blessed and important award a vital tribute to Israel's allies among the next generation" JERUSALEM, Sept. 17, 2025 ...